+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-11-07Number of Pages: 116

Cervical Dysplasia Market (Diagnostics - Diagnostic Tests (Pap Smear Test, HPV Test, Biopsy), Diagnostic Devices (Colposcopy); End User - Hospitals, Diagnostic Centers, Private Gynecologists’ Offices, Research and Academic Institutes, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Global Cervical Dysplasia Market: Snapshot

Cervical dysplasia is one of the fastest growing market in the field of cancer diagnosis and treatment. Cervical cancer is a precancerous stage and it can be completely cured by early detection. Rising consumer awareness in this regard has led to an increased demand for cervical screenings in the past few years. Government bodies in several developed countries conduct screening programs in order to improve the quality of life of population by reducing the mortality rate. Furthermore, recommendations from government organization for early detection of chronic diseases including cervical dysplasia is one of the major factors that is expected to drive the overall cervical dysplasia market over the forecast period.

Transparency Market Research states that the global cervical dysplasia market was valued at US$349.0 mn in 2015 and will expand at a CAGR of 7.0 % during the period between 2016 and 2024, to reach US$ 640.2 mn by 2024.

cervical dysplasia market

Thanks to High Accuracy and Low Cost, HPV Tests to See Vast Rise in Demand

Based on diagnosis, the market has been segmented into diagnostic tests and diagnostic devices. Furthermore, the diagnosis test segment is examined for Pap smear (Papanicolaou) test, HPV (human papillomavirus) test, and biopsy. Colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Of these, the segment of diagnostic tests accounted for around 86.3% of the market in terms of revenue in 2015. Availability of reimbursement for cervical dysplasia screening tests in mature markets such as North America and Europe is one of the key factors expected to fuel the sales of cervical dysplasia diagnostic tests market in the next few years.

Of the key cervical dysplasia diagnostic tests analyzed in the report, the segment of HPV tests is expected to grow at a higher CAGR over the forecast period owing to the rising aversion to Pap smear tests and advancements in HPV testing technologies. The significant false-negative rate and high costs of Pap smear tests have resulted in a vast decline in their demand, with the more accurate and cost-effective HPV testing emerging as one of the primary screening tool recommended by healthcare providers these days.

Developed Economies to Continue Being Most Lucrative

Geographically, North America was the dominant market for cervical dysplasia in 2015. The region accounted for a share of over 55.2% of the global cervical dysplasia market in the said year. Rising awareness about cervical dysplasia screening programs and technological advancements in screening devices and other supporting equipment are the key factors fueling the growth of the North America cervical dysplasia market. The diagnosis test segment in North America dominated, accounting for over 85% in the regional market in 2015. The increasing incidence rate of cervical cancer in women above the age of 50 years and favorable reimbursement policies supported by federal organizations such as Medicare are also expected to drive the market in North America in the next few years.

The cervical dysplasia market in Asia Pacific is anticipated to witness the most promising growth rate during the forecast period, chiefly owing to the improving healthcare infrastructure and encouraging government funding on cancer research in the region. The markets in emerging economies such as India and China are expected to exhibit significant expansion in the next few years. Several government-funded cervical dysplasia screening programs in these countries, initiated with the aim of reducing the mortality rate by improving the quality of life of the population will be a key driver of the market.

Some of the key players operating in the global cervical dysplasia market are F. Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt Ltd.

Section - 1 Preface 
1.1 Report Scope and Market Segmentation 
1.2 Research Highlights

Section - 2 Assumptions and Research Methodology 
2.1 Assumptions and Acronyms Used
2.2 Research Methodology

Section-3 Executive Summary
3.1 Global Cervical Dysplasia: Market Snapshot
3.2 Global Cervical Dysplasia Market: Opportunity Map

Section-4 Market Overview
4.1 Global Cervical Dysplasia Market: Key Industry Developments

Section-5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
       5.1.2 Drivers
               5.1.2.1 Increasing cervical screening programs
               5.1.2.2 Rising Prevalence of Cervical Cancer in aging population
               5.1.2.3 Government Funding On Cancer Screening Programs
               5.1.2.4 Favorable Government policies
               5.1.2.5 Awareness campaigns 
               5.1.2.6 Increasing Cigarette Smokers around the Globe
               5.1.2.7 Government organization recommendations
       5.1.3 Restraints
               5.1.3.1 Low awareness in underdeveloped countries hinders the growth of the market 
               5.1.3.2 HPV vaccination recommendations
               5.1.3.3 Changes in Government Policies 
5.2 Global Cervical Dysplasia Market Revenue Projection
5.3 Porter’s Five Forces Analysis
5.4 Cervical Dysplasia Market Outlook

Section-6 Cervical Dysplasia Market Analysis, By Diagnosis
6.1 Key Findings
6.2 Introduction
6.3 Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type
6.4 Global Cervical Dysplasia Market Forecast, By Diagnosis Type
       6.4.1 Diagnostic Test
               6.4.1.1. HPV Test
               6.4.1.2. Pap Smear Test
               6.4.1.3. Biopsy
       6.4.2 Diagnostic Devcie
6.4.2.1. Colposcopy
6.5 Global Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type

Section-7 Global Cervical Dysplasia Market Analysis, By End User
7.1 Key Findings
7.2 Introduction
7.3 Global Cervical Dysplasia Market Value Share Analysis, By End User
7.4 Global Cervical Dysplasia Market Forecast, By End User
       7.4.1 Hospitals
       7.4.2 Diagnostic Centers
       7.4.3 Ambulatory Surgical Centers
       7.4.4 Private Gynecologist’s Offices
       7.4.5 Research & Academic institutes
7.5 Global Cervical Dysplasia Market Attractiveness Analysis, By End User

Section-8 North America Cervical Dysplasia Market Analysis
8.1 Key Findings
8.2 North America Cervical Dysplasia Market Overview
8.3 North America Market Value Share Analysis, By Diagnosis Type
       8.3.1 North America Market Forecast, By Diagnosis Type
8.4 North America Market Value Share Analysis, By End User
       8.4.1 North America Market Forecast, By End User
8.5 North America Market Forecast, By Country
8.6 North America Market Attractiveness Analysis
8.7 North America Market Trends

Section-9 Europe Cervical Dysplasia Market Analysis
9.1 Key Findings
9.2 Europe Cervical Dysplasia Market Overview
9.3 Europe Market Value Share Analysis, By Diagnosis Type
       9.3.1 Europe Market Forecast, By Diagnosis Type
9.4 Europe Market Value Share Analysis, By End User
       9.4.1 Europe Market Forecast, By End User
9.5 Europe Market Forecast, By Country
9.6 Europe Market Attractiveness Analysis
9.7 Europe Market Trends

Section-10 Asia Pacific Cervical Dysplasia Market Analysis
10.1 Key Findings
10.2 Asia Pacific Cervical Dysplasia Market Overview
10.3 Asia Pacific Market Value Share Analysis, By Diagnosis Type
       10.3.1 Asia Pacific Market Forecast, By Diagnosis Type
10.4 Asia Pacific Market Value Share Analysis, By End User
       10.4.1 Asia Pacific Market Forecast, By End User
10.5 Asia Pacific Market Forecast, By Country
10.6 Asia Pacific Market Attractiveness Analysis
10.7 Asia Pacific Market Trends

Section-11 Latin America Cervical Dysplasia Market Analysis
11.1 Key Findings
11.2 Latin America Cervical Dysplasia Market Overview
11.3 Latin America Market Value Share Analysis, By Diagnosis Type
       11.3.1 Latin America Market Forecast, By Diagnosis Type
11.4 Latin America Market Value Share Analysis, By End User
       11.4.1 Latin America Market Forecast, By End User
11.5 Latin America Market Forecast, By Country
11.6 Latin America Market Attractiveness Analysis
11.7 Latin America Market Trends

Section-12 Middle East and Africa Cervical Dysplasia Market Analysis
12.1 Key Findings
12.2 Middle East and Africa Market Overview
12.3 Middle East and Africa Market Value Share Analysis, By Diagnosis Type
       12.3.1 Middle East and Africa Market Forecast, By Diagnosis Type
12.4 Middle East and Africa Market Value Share Analysis, By End User
       12.4.1 Middle East and Africa Market Forecast, By End User
12.5 Middle East and Africa Market Forecast, By Country
12.6 Middle East and Africa Market Attractiveness Analysis

Section-13 Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
       13.2.1. Becton, Dickinson and company.
               13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.1.2. Financial Overview
               13.2.1.3. Diagnosis Portfolio
               13.2.1.4. SWOT Analysis
               13.2.1.5. Strategic Overview
       13.2.2 Hologic, Inc
               13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.2.2. Financial Overview
               13.2.2.3. Diagnosis Portfolio
               13.2.2.4. SWOT Analysis
               13.2.2.5. Strategic Overview
       13.2.3 Micromedic Technologies Ltd.
               13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.3.2. Financial Overview
               13.2.3.3. Diagnosis Portfolio
               13.2.3.4. SWOT Analysis
               13.2.3.5. Strategic Overview
       13.2.4 OncoHealth Corporation 
               13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.4.2. Financial Overview
               13.2.4.3. Diagnosis Portfolio
               13.2.4.4. SWOT Analysis
               13.2.4.5. Strategic Overview
       13.2.5 Quest Diagnostics, Inc 
               13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.5.2. Financial Overview
               13.2.5.3. Diagnosis Portfolio
               13.2.5.4. SWOT Analysis
               13.2.5.5. Strategic Overview
       13.2.6 F. Hoffmann La-Roche Ltd. 
               13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.6.2. Financial Overview
               13.2.6.3. Diagnosis Portfolio
               13.2.6.4. SWOT Analysis
               13.2.6.5. Strategic Overview
       13.2.7 QIAGEN N.V.
               13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.7.2. Financial Overview
               13.2.7.3. Diagnosis Portfolio
               13.2.7.4. SWOT Analysis
               13.2.7.5. Strategic Overview
       13.2.8 Abbott Laboratories
               13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
               13.2.8.2. Financial Overview
               13.2.8.3. Diagnosis Portfolio
               13.2.8.4. SWOT Analysis
               13.2.8.5. Strategic Overview

List of Figures

Figure01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure02: Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure03: Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type
Figure04: Global Cervical Dysplasia Market Value Share Analysis, by End-user, 2016 and 2024
Figure05: Cervical Dysplasia Market Attractiveness Analysis, by End-user
Figure06: Global Cervical Dysplasia Market Value Share Analysis, by Region, 2016 and 2024
Figure07: Cervical Dysplasia Market Attractiveness Analysis, by Region
Figure09: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure10: North America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure11: North America Market Attractiveness Analysis, by Country
Figure12: North America Market Value Share Analysis, by Diagnosis Type, 2016 and 2024
Figure13: North America Market Value Share Analysis, by End-User, 2016 and 2024
Figure14: North America Market Value Share Analysis, by Country, 2016 and 2024
Figure15: North America Market Attractiveness Analysis, by Diagnosis Type 
Figure16: North America Market Attractiveness Analysis, by End-user
Figure17: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure21: Europe Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure22: Europe Market Attractiveness Analysis, By Country
Figure23: Europe Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure24: Europe Market Value Share Analysis, By End User, 2016 and 2024
Figure25: Europe Market Value Share Analysis, By Country, 2016 and 2024
Figure26: Europe Market Attractiveness Analysis, by Diagnosis 
Figure27: Europe Market Attractiveness Analysis, by End User 
Figure28: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) and Forecast, 2015–2024
Figure29: Asia Pacific Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure30: Asia Pacific Market Attractiveness Analysis, By Country
Figure31: Asia Pacific Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure32: Asia Pacific Market Value Share Analysis, By End User, 2016 and 2024
Figure33: Asia Pacific Market Value Share Analysis, By Country, 2016 and 2024
Figure34: Asia Pacific Market Attractiveness Analysis, by Diagnosis 
Figure35: Asia Pacific Market Attractiveness Analysis, by End User 
Figure36: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure37: Latin America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure38: Latin America Market Attractiveness Analysis, By Country
Figure39: Latin America Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure40: Latin America Market Value Share Analysis, By End User, 2016 and 2024
Figure41: Latin America Market Value Share Analysis, By Country, 2016 and 2024
Figure42: Latin America Market Attractiveness Analysis, by Diagnosis 
Figure43: Latin America Market Attractiveness Analysis, by End User 
Figure44: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
Figure45: Middle East and Africa Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
Figure46: Middle East and Africa Market Attractiveness Analysis, By Country
Figure47: Middle East and Africa Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
Figure48: Middle East and Africa Market Value Share Analysis, By End User, 2016 and 2024
Figure49: Middle East and Africa Market Value Share Analysis, By Country, 2016 and 2024
Figure50: Middle East and Africa Market Attractiveness Analysis, by Diagnosis 
Figure51: Middle East and Africa Market Attractiveness Analysis, by End User 

List of Tables

Table 01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 02: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2016–2024
Table 03: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by Region, 2015–2024
Table 04: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Diagnosis Type, 2015–2024
Table 05: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2015–2024
Table 06: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Country, 2015–2024
Table 07: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 08: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 09: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 10: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 11: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 12: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 13: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 14: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
Table 16: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024

Global Cervical Dysplasia Market: Scope and Methodology

This report on the global cervical dysplasia market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the global cervical dysplasia market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global cervical cancer market.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of cancer and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.

Cervical Dysplasia Market: Segmentation

Based on the diagnosis, the market has been further segmented into two major segments namely, diagnosis tests and diagnostic devices. Diagnosis segment further sub-segmented into Pap smear test, HPV test, and Biopsy. Moreover, colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Based on end user, the market has been segmented into hospitals, diagnostic centers, private gynecological offices, research & academic institutes and ambulatory surgical centers.

Cervical Dysplasia Market: Geographical and Competitive Dynamics

Geographically, the global cervical dysplasia market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, Japan, India, Saudi Arabia, UAE, Brazil, and Mexico.

The report also profiles major players in the cervical dysplasia market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include F. Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt Ltd, exhibit the largest geographical outreach with presence in cervical dysplasia product categories.

The global cervical dysplasia market is segmented as follows:

Global Cervical Dysplasia Market Revenue, by Diagnosis

  • Diagnosis Test
    • Pap Smear Test
    • HPV Test
    • Biopsy
  • Diagnostic Device
    • Colposcopy

Global Cervical Dysplasia Market Revenue, by End User

  • Hospitals
  • Diagnostic Centers
  • Private Gynecologists’ Offices
  • Research & Academic Institutes
  • Ambulatory Surgical Centers

Global Cervical Dysplsia Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa


 
 
Back To Top